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O-Glycosylation of the N-terminal
Region of the Serine-rich Adhesin Srr1
of Streptococcus agalactiae Explored by Mass
Spectrometry*□S
Thibault Chaze‡§¶¶, Alain Guillot¶, Benoît Valotb, Olivier Langella,
Julia Chamot-Rooke¶¶, Anne-Marie Di Guilmi**, Patrick Trieu-Cuot‡‡§§,
Shaynoor Dramsi‡‡§§, and Michel-Yves Mistou‡§a
Serine-rich (Srr) proteins exposed at the surface of
Gram-positive bacteria are a family of adhesins that
contribute to the virulence of pathogenic staphylococci
and streptococci. Lectin-binding experiments have pre-
viously shown that Srr proteins are heavily glycosylated.
We report here the first mass-spectrometry analysis of
the glycosylation of Streptococcus agalactiae Srr1. After
Srr1 enrichment and trypsin digestion, potential glyco-
peptides were identified in collision induced dissocia-
tion spectra using X! Tandem. The approach was then
refined using higher energy collisional dissociation
fragmentation which led to the simultaneous loss of
sugar residues, production of diagnostic oxonium ions
and backbone fragmentation for glycopeptides. This
feature was exploited in a new open source software tool
(SpectrumFinder) developed for this work. By combining
these approaches, 27 glycopeptides corresponding to six
different segments of the N-terminal region of Srr1 [93–
639] were identified. Our data unambiguously indicate
that the same protein residue can be modified with differ-
ent glycan combinations including N-acetylhexosamine,
hexose, and a novel modification that was identified as O-
acetylated-N-acetylhexosamine. Lectin binding and mono-
saccharide composition analysis strongly suggested that
HexNAc and Hex correspond to N-acetylglucosamine and
glucose, respectively. The same protein segment can be
modified with a variety of glycans generating a wide struc-
tural diversity of Srr1. Electron transfer dissociation was
used to assign glycosylation sites leading to the unambig-
uous identification of six serines and one threonine resi-
dues. Analysis of purified Srr1 produced in mutant strains
lacking accessory glycosyltransferase encoding genes
demonstrates that O-GlcNAcylation is an initial step in Srr1
glycosylation that is likely required for subsequent decora-
tion with Hex. In summary, our data obtained by a combi-
nation of fragmentation mass spectrometry techniques as-
sociated to a new software tool, demonstrate glycosylation
heterogeneity of Srr1, characterize a new protein modifica-
tion, and identify six glycosylation sites located in the N-ter-
minal region of the protein. Molecular & Cellular Pro-
teomics 13: 10.1074/mcp.M114.038075, 2168–2182, 2014.
Protein glycosylation takes place in bacteria. A consider-
able amount of information on the biochemical pathways
involved in protein glycosylation has been obtained in the
genera Campylobacter and Neisseria (1–3). Hence, functional
studies performed on Gram-negative bacteria have revealed
important properties of protein glycosylation pathways. Like
in eukaryotes, proteins can be glycosylated on asparagines
(N-glycosylation) or serine/threonine residues (O-glycosyla-
tion). Two modes of glycan transfer onto proteins have been
characterized in Gram-negative bacteria. In the first, the ac-
tivated glycan is synthesized on a lipid carrier on the cyto-
plasmic side of the membrane. After membrane translocation,
the glycan portion of the polyprenyl-phosphate-glycan inter-
mediate is transferred en bloc to the protein by an oligosac-
charyltransferase active in the periplasm. Such mechanism
has been demonstrated for N-glycosylation in Campylobacter
jejuni (4–6) and O-glycosylation in Neisseria gonorrheae (7–9).
These pathways are responsible for the glycosylation of more
than 65 proteins in C. jejuni (10) and 12 different proteins in N.
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gonorrheae (11). The second well-characterized type of trans-
fer is sequential and arises in the cytoplasm: glycosyltrans-
ferases (GTs)1 catalyze the transfer of monosaccharide resi-
dues, under a nucleotide-diphosphate activated form, in a
stepwise manner to the protein. This mechanism has long
been considered to be restricted to O-glycosylation like in
Campylobacter, Helicobacter, or Pseudomonas spp. for fla-
gellar proteins (12–15). However, it was recently demon-
strated that HMW1c, a GT of Haemophilus influenzae, was
responsible for the cytoplasmic N-glycosylation of the adhe-
sin HMW1 (16, 17).
Important families of glycoproteins have also been charac-
terized in Gram-positive bacteria. The glycosylation of flagel-
lins has been demonstrated in Clostridium spp. and in Listeria
monocytogenes (13, 18); the modification is required for fla-
gella assembly in C. difficile (13) and motility in L. monocyto-
genes (19, 20). In L. monocytogenes, the flagellin monomer is
modified with N-acetylglucosamine (GlcNAc) residues at up to
six different sites by GmaR, a cytoplasmic O-GlcNAc-trans-
ferase (OGT) homologous to eukaryotic OGTs (18). GmaR was
the first prokaryotic enzyme of this type to be characterized
(20). The type of sugar added to flagellins and the number of
modified sites is different between species and is even strain-
dependent in Clostridium difficile (13). Genomic analysis sug-
gests that flagellin glycosylation in Clostridium spp. is per-
formed on proteins through a sequential process in the
cytoplasm (3). In mycobacteria and other actinomycetae, a
general O-mannosylating system has been identified which
involves a transmembrane O-mannosyltransferase similar to
that found in eukaryotes (21–24). Importantly, in Mycobacte-
rium tuberculosis the disruption of the pathway responsible of
adhesins mannosylation was found to strongly attenuate its
virulence (21). The glycosylation of surface (S-) layer proteins
which cover the cell surface of a variety of bacterial species is
a common modification of this class of proteins (25, 26). The
extensive MS analysis performed in mutant backgrounds on
the S-layer proteins of Geobacillus stearothermophilus and
Paenibacillus alvei have made possible the reconstruction of
the biosynthesis pathway for S-layer glycans, and also to
propose a model for their export and transfer to S-layer pro-
teins (27, 28). Interestingly, the P. alvei study also revealed
that tyrosine residues can be modified by a bacterial protein
glycosylation pathway (28). More recently cell wall autolysins
expressed in different Lactobacilli spp. have been shown to
be glycosylated (29–31); interestingly, the peptidoglycan hy-
drolytic activity of the autolysin Acm2 of Lactobacillus plan-
tarum was found to be controlled by O-glycosylation (30).
Although a large array of glycoproteins proteins have been
characterized, it is notable that only O-type glycosylation has
been described so far in Gram-positive bacteria.
Recently, a family of serine-rich (Srr) glycosylated pro-
teins has been discovered in Streptococcus species and
Staphylococcus aureus (32, 33). Well-studied members in-
clude the fimbriae-associated adhesin Fap1 of Streptococ-
cus parasanguinis (34), the human-platelet binding protein
GspB of Streptococcus gordonii (35), the SraP and PsrP
adhesins of Staphylococcus aureus and Streptococcus
pneumoniae, respectively (36, 37) and the Srr1 adhesin of S.
agalactiae (36, 38–42). These proteins are exported to the
cell surface through a dedicated transport system called
SecA2 and are covalently anchored to peptidoglycan. Ge-
nome comparisons revealed striking similar genetic organi-
zation of srr loci characterized by the presence of a gene
cluster encoding the Srr-dedicated secretion machinery
(SecA2 secretion system) and a variable number of GTs (32,
33, 43). The role of Srr proteins as major bacterial adhesins
was first demonstrated in the oral streptococci Streptococ-
cus gordonii and Streptococcus parasanguinis (formerly S.
sanguis) where they are required for full adhesion of bacte-
rial cells to platelets or saliva-coated hydroxylapatite, re-
spectively (34, 44). In the human pathogens S. aureus and
S. pneumoniae, the Srr proteins corresponding to SraP and
PrsP were shown to promote adhesion to platelets and lung
cells, respectively (36, 37, 45). Importantly, Srr proteins
have been associated with the virulence of all of these
opportunistic pathogens (34, 36, 37, 45, 46).
Streptococcus agalactiae is the leading cause of sepsis and
meningitis in neonates (47, 48). The species colonizes asymp-
tomatically the mucosa of 20–30% of the human population
and is an increasing cause of invasive infections in immuno-
compromised adults (49). S. agalactiae Srr1 is involved in
adhesion to endothelial and epithelial cells (38–42,50). Such
surface proteins are attractive vaccine candidates and S.
agalactiae Srr protein has been shown to confer immunogenic
protection in mice (51).
Srr1 binds both keratin 4 and fibrinogen through the same
N-terminal binding region located between amino acid resi-
dues 303 and 641 (Fig. 1A) (39, 42, 52). Upstream of this
binding domain, Srr1 displays two non-repeated regions (NR1
and NR2) showing no homology with known proteins which
are separated by a first serine-rich region (SR1) where the
proportion of the Ser/Thr residues is above 40%. The C-ter-
minal part of Srr1 (SR2) contains more than 70% of Ser/Thr
residues with 140 repetitions of the SASM/T motif that ex-
tends over 700 residues (Fig. 1A and supplemental Fig. S1).
The C terminus also contains a LPXTG motif that is recog-
1 The abbreviations used are: GT, glycosyltransferase; BR, binding
region; BSN, Bjerrum and Shaffer Nielsen buffer; CID, collision induced
dissociation; ETD, electron transfer dissociation; Glc, glucose; GlcNAc,
N-acetylglucosamine; HCD, higher energy collisional dissociation; Hex,
hexose; HexNAc, N-acetylhexosamine; ISF, in source fragmentation;
MS/MS, tandem mass spectrometry; NCE, normalized collision energy;
NR, non repeat region; O-AcHexNAc, O-acetylated-N-acetylhexo-
samine; PAGE, polyacrylamide gel electrophoresis; SF, Spectrum-
Finder; SR, serine-rich (region); Srr, serine-rich (protein); sWGA, succi-
nylated wheat germ agglutinin; TFA, trifluoroacetic acid; TH, Todd-
Hewitt broth; Tris, 2-amino-2-hydroxymethyl-1,3-propanediol; WGA,
wheat germ agglutinin; XIC, extracted ion chromatogram.
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nized by sortase for covalent attachment of Srr1 to the pep-
tidoglycan (53). The Srr proteins synthesized in Streptococcus
spp. and S. aureus exhibit a similar organization with variation
in the functional binding domains and in the length of the
C-terminal SR domain (32). We previously carried out an
extensive functional analysis of the srr1-secA2 locus of S.
agalactiae (38) (Fig. 1B). Genetic and biochemical data
showed that the GTs GtfA and GtfB were essential for the
addition of a N-acetylglucosamine (GlcNAc) to Srr1 and that
six other GTs (GtfC to GtfH) were potentially involved in ad-
ditional glycan modifications (38). It was also demonstrated
for Srr1 and GspB that glycosylation takes place in the cyto-
plasm (38, 54).
We report here the first detailed analysis of Srr1 glycosyla-
tion at the molecular level by means of mass spectrometry.
Lectin affinity chromatography was used to enrich Srr1 before
trypsin digestion Fig. 1C. Tryptic peptides were then analyzed
by nanoLC-tandem MS (MS/MS) using various activation
techniques. A dedicated software tool SpectrumFinder (SF),
allowing the retrieval of glycopeptides after higher energy
collisional dissociation (HCD) fragmentation was developed
for this study. This combination of approaches led to the
identification of 27 glycopeptides in the N-terminal part of the
protein, outside the region containing the highest serine den-
sity. We demonstrated that besides glycosylation by N-acetyl-
hexosamine (HexNAc) or hexose (Hex) residues, Srr1 can also
be modified by an unexpected sugar characterized as O-
acetylated–N-acetylhexosamine (O-AcHexNAc). To localize
glycosylation sites, electron transfer dissociation (ETD) exper-
iments were performed. We were able to identify six glycosy-
lation sites that were associated to five serine and one thre-
onine residues.
EXPERIMENTAL PROCEDURES
Chemicals—Cultures media were from BD (Beckton, Dickinson and
Company, Sparks, MD). Water used was ultra-pure water obtained
with a Milli-Q purifier (Millipore SAS, Molsheim, France). Lectins were
from Vector laboratories (Vector Laboratories, Burlingame, CA, USA).
The other chemicals were from Sigma Aldrich (Sigma-Aldrich, St.
Louis, MO, USA) except when indicated. Antibodies were prepared as
described (15).
Bacterial Strains, Culture Media and Growth Conditions—Strepto-
coccus agalactiae H36B is a serotype Ib strain whose genome has
been sequenced (29). This strain was chosen because of its high Srr1
production level, as compared with S. agalactiae NEM316 strain. To
produce Srr1, we used the H36BSrtA* mutant strain where the cata-
lytic residue Cys206 of the sortase A protein was changed into alanine
by engineering the srtA gene (gbs0949) as described (55). As a
consequence, the secreted proteins carrying a LPXTG motif like Srr1
were more efficiently released into the culture medium (53). This
mutation does not affect Srr1 glycosylation as this post-translational
modification is a cytoplasmic event taking place prior to the export
process (38). To study the role of accessory GTs (GtfC-H) and the
sequence of glycosylation events, the strain H36BSrtA*gtfCH was
constructed as previously described (38). S. agalactiae strains were
cultured in Todd-Hewitt (TH) broth in standing filled flasks at 37 °C.
Srr1 Protein Production—Bacterial cell were removed from culture
medium (1 liter) by centrifugation (10 min at 6000  g) and the
supernatant was filtered to 0.22 m. The proteins released in medium
during growth were precipitated overnight with ammonium sulfate
(30%) at 4 °C under gentle agitation. Protein pellet obtained after
centrifugation (15 min at 15,000  g) was resuspended in 10 ml
Wheat germ agglutinin (WGA) buffer (20 mM Tris, and 200 mM NaCl,
pH 7.5) and dialyzed on Float-a-lyzer G2 10kDa (Spectrum lab, Breda,
NL) overnight against WGA buffer. For lectin affinity chromatography,
FIG. 1. Modular organization of Srr1, scheme of srr1 locus and production of Srr1. A, The different domains of the 1310 residues
in-length Srr1 protein of S. agalactiae are shown. SP: Signal peptide; NR: Non repeat region; SR: Serine rich region; BR: Binding region; LPXTG:
domain containing the LPXTG-cell wall anchoring motif. Residues numbering is shown. B, Schematic view of the 23 kb srr1 locus. The genes
encoding GTs are colored in green. Light Green for accessory GTs-encoding genes (gtfC to gtfH), dark green for essential GTs-encoding genes
(gtfA and gtfB). In blue, the genes encoding proteins related to Srr1 secretion. In the opposite transcriptional orientation, in red, the rga gene
encodes a positive transcriptional regulator of srr1 (gray). The embrace highlights the region deleted in the H36BSrtA*gtfCH mutant strain.
C, SDS-PAGE of Srr1 containing fractions. Lane 1: Supernatant of the medium after an over-night culture of H36B SrtA* strain. Lane 2:
Supernatant concentrated 20-fold. Lane 3: Srr1 containing fraction after purification on WGA agarose column. Lane 4: Western blot analysis
using polyclonal anti-Srr1 serum. Lane 5: Lectin blot analysis using biotinylated WGA. Arrowheads point to Srr1 band. The same proportion
(5%) of the samples were loaded before (lane 2) and after (lane3) purification to highlight the efficiency of the purification procedure.
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a 5/50 column (Amersham Bioscience) was packed with one ml
WGA-agarose conjugate. The chromatographic steps were run on
an A¨kta purifier (Amersham Bioscience). The column was thor-
oughly washed with WGA buffer and protein sample was loaded at
0.1 ml/min at 4 °C. After a washing step with 10 ml WGA buffer,
WGA bound proteins were eluted with 1 ml elution buffer (20 mM
Tris, 200 mM NaCl, and 500 mM N-acetyl-D-glucosamine, pH 7.5) at
0.5 ml/min. Protein fractions were extensively dialyzed against 20
mM Tris, 200 mM NaCl, pH 7.5 on 10 KDa cut-off membrane Amicon
Ultra, Millipore, Billerica, MA. Concentrated fractions were stored at
20 °C until further analysis. For the comparative analysis of Srr1
produced in H36BSrtA* and H36BSrtA*gtfCH, the culture super-
natants were concentrated 100-fold and loaded on SDS-PAGE (see
next section). The Coomassie-stained protein band corresponding
to Srr1 was excised and trypsin-treated as described below (Gen-
eration of Srr1 tryptic peptides).
SDS-PAGE, Blotting, Lectin Binding, and Immunodetection—Pro-
tein fractions were resolved on precast Criterion XT Bis Tris Gel
4–12% run in XT-MOPS buffer (Bio-Rad Life Sciences, Marnes-la-
Coquette, France). Gels were stained using colloidal Coomassie dye
G250 (GelCode, Thermo Fisher Scientific Inc, Rockford, IL, USA). For
immunodetection or lectin binding, gels were washed in water and
sunk in Bjerrum and Shaffer Nielsen buffer (BSN buffer): 48 mM Tris,
39 mM glycine, and 20% methanol, pH 9.2. Proteins were transferred
on nitrocellulose or methanol activated PVDF membrane after their
immersion in BSN buffer. Semi-dry transfer was done using Trans-
blot S.D. apparatus (Bio-Rad) at 20 V for 30 min. Membrane were
washed once in water and then in PBS Tween 0.1% (PBS-T). Mem-
brane were blocked in PBS-T, 3% BSA (PBS-T-B) for 30 min. Anti-
Srr1 polyclonal antibodies were used at 1:1000 dilution in PBS-T-B
and membrane was incubated 1 h at room temperature or overnight
at 4 °C. After three washes of 10 min in PBS-T, membranes were
incubated with Alexa-488 (Invitrogen, Invitrogen SAS, St. Aubin,
France) conjugated secondary antibody diluted 1:5000 in PBS-T-B.
For lectin binding, succinylated WGA (sWGA) conjugated to fluores-
cein (Vector laboratories, Burlingame, CA) was used at a 1:2000
dilution. Membranes were scanned for fluorescence detection using a
FLA-3000 instrument (Fuji photo film, Tokyo, Japan).
Compositional Analysis of Srr1-associated Monosaccharides—
Monosaccharide composition of purified Srr1 was determined as
trimethylsilyl derivatives by gas chromatography and mass spectrom-
etry (GC-MS) after acid hydrolysis. Purified Srr1 was spotted on PVDF
membrane and extensively washed in water. Hydrolysis of glycosidic
bond was achieved by transferring the membrane in 100 l of 4 M
trifluoroacetic acid (TFA) for three hours at 110 °C.
The hydrolysate was dried under vacuum and resuspended in 100
l of the derivatization mixture containing 1.34 M N-methyl-N-(tri-
methyl-silyl)-trifluoroacetamide (MSTFA) (Sigma-Aldrich) and 0.5 mM
of xylose in pyridine as internal standard. The trimethylsilyl derivatives
of carbohydrates were analyzed by GC-MS with an Agilent system
(GC 6890 and MS 5973N, Agilent Technologies, Santa Clara, CA).
Samples were injected with an automatic injector (Gerstel PAL, Sur-
see, Switzerland). Gas chromatography was performed on a 30 m
ZB-50 column with 0.25 mm inner diameter and 0.25 m film thick-
nesses (Phenomenex, Torrence, CA). Helium was used as the carrier
gas and set at a constant flow rate of 1.5 ml/min. The temperature
program was 5 min isothermal heating at 80 °C, followed by a 20 °C/
min oven temperature ramp to 300 °C, and a final 3 min heating at
300 °C. Compounds were identified by both their retention time and
comparison of their electron ionization mass spectra profiles with
those of the NIST 05 Mass spectral library (Scientific Instrument
Services, Ringoes, NJ, USA). The quantification was done using an
external standard calibration curves for each molecule (2.5–25 nmol
injected) established with the peak area of specific ion and expressed
in nmol/mg cell walls.
Srr1 Tryptic Digestion—Coomassie-stained Srr1 bands detected
on gel were cut and rinsed in water. Tryptic digestion was performed
in-gel by adding 200 ng sequencing grade modified trypsin (Promega
France, Charbonnie`res, France) diluted in 25 mM NH4HCO3 for 18 h at
37 °C. Tryptic peptides were recovered by washing the gel pieces twice
in 0.2% TFA-50% acetonitrile and once in 100% acetonitrile and the
supernatant was evaporated to dryness. Srr1 alkylation was deliberately
omitted before mass spectrometry analysis to avoid formation of S-
carbamidomethylmethionine (CMM) on methionyl residues resulting
from iodoacetamide treatment (there are 45 methionines in Srr1) (56).
Upon collision induced dissociation (CID) fragmentation, CMM gives a
typical neutral loss of 105 Da that is interfering with our manual research
of glycan neutral loss. Srr1 contains only one cysteine residue.
LC-MS/MS (CID) of Srr1 Tryptic Digest—Liquid chromatography
(LC) was performed on an Ultimate 3000 RSLC Nanosystem (Dionex,
Thermo Scientific). The sample was loaded on a precolumn cartridge,
desalted with 0.08% TFA and 2% acetonitrile, and peptides separa-
tion was achieved on a PepMap C18 column (stationary phase: C18
PepMap 100, 3 m; column: 75 m i.d., 150 mm; Dionex). Buffers
were 0.1% formic acid, 2% acetonitrile (A) and 0.1% formic acid, and
80% acetonitrile (B). Peptide separation was achieved with a linear
gradient from 0% to 38% B for 50 min at 300 nl/min at 40 °C.
Separated peptides were analyzed on-line with a LTQ-Orbitrap Dis-
covery mass spectrometer (Thermo Electron SAS, Villebon, France)
using a nanoelectrospray interface. Ionization (1.5 kV ionization poten-
tial) was performed in positive mode with liquid junction and a capillary
probe (10 m i.d.; New Objective). Peptide ions were analyzed using
Xcalibur 2.07 with the following data-dependent acquisition steps: 1) full
MS scan in orbitrap (mass-to-charge ratio (m/z) 600 to 2000, profil
mode, resolution 30,000 at m/z 400); and 2) MS/MS in linear trap (qz
0.22, activation time 50ms, and normalized collision energy (NCE) 35%;
centroid mode). Step 2 was repeated for the four major ions detected in
step 1. Singly charged ions were excluded and dynamic exclusion time
was set to 60 s. To enhance mass accuracy in Orbitrap mass analyzer,
the lock mass option was activated on dimethylcyclosiloxan (m/z
667.1764).
In Source Fragmentation (ISF) in LTQ-Orbitrap—ISF was used to
form oxonium ions of interest by applying a capillary voltage of 80 V.
Oxonium ions were further fragmented by CID in the LTQ using 40
NCE.
LC-MS/MS (HCD) of Srr1 Tryptic Digest—LC was performed with a
NanoLC-Ultra Eksigent system. The sample was loaded at a flow rate
of 7.5 l/min onto a precolumn cartridge (Biosphere C18, 5 m, 20
mm, 100 m i.d.; NanoSeparations, Nieuwkoop, NL) with 0.1% (v/v)
formic acid and 2% acetonitrile. After 3 min, the precolumn cartridge
was connected to the separating column (Biosphere C18, 3 m, 150
mm, 75 m i.d.; NanoSeparations Nieuwkoop, NL). The buffers used
were water (buffer A) and acetonitrile (buffer B) each containing 0.1%
(v/v) formic acid. Peptides were separated using a linear gradient from
5% to 35% B for 37 min at 300 nl/min.
A Q Exactive mass spectrometer (ThermoFisher Scientific) with
nanoelectrospray interface was used for peptide analysis. Ionization
(1.5 kV ionization potential) was performed in positive mode using a
liquid junction and a capillary probe (10 m i.d.; New Objective).
Peptide ions were analyzed using Xcalibur 2.2 with the following
data-dependent acquisition steps: 1) full MS scan (mass-to-charge
ratio (m/z) 600 to 2500, resolution 70,000 at m/z 400); and 2) MS/MS
scan using Quadrupole selection (window of 3 Th) and HCD (NCE 30,
resolution 17,500). Step 2 was repeated for the ten most intense ions
(top 10) detected in step 1. Singly charged ions were excluded and
dynamic exclusion time was set to 40 s. Lock mass option was
activated using m/z 667.1764 of dimethylcyclosiloxan.
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LC-MS/MS (ETD) of the Srr1 Tryptic Digest—LC was performed on
an ultimate 3000 nanoLC (Dionex, Thermoscientific). Sample was
loaded at 30 l/min on a precolumn cartridge (stationary phase: C18
PepMap 100, 5 m; column: 300 m i.d., 5 mm; Dionex) and desalted
with 0.1% TFA and 2% acetonitrile. After 3 min of loading, the
precolumn cartridge was connected to an in-house separating C18
column (Reprosil C18-HD, 3 m, column 75 m i.d., 150 mm, Cluzeau
France). Buffers were 0.1% formic acid, 2% acetonitrile (A) and 0.1%
formic acid and 80% acetonitrile (B). Peptide separation was
achieved with a linear gradient from 0% to 42% B for 35 min at 300
nl/min at 35 °C.
Two types of acquisition (using Xcalibur 2.1) were used. The first
one was a combined CID/ETD run and is based on a i) full MS scan in
the Orbitrap (m/z 300 to 2000) at resolution 15,000 (at m/z 400) and ii)
CID and ETD MS/MS spectra (max 5 precursor ions) with analysis in
the linear ion trap. In the second type of run, only ETD was used for
MS/MS including all glycopeptide ions previously identified. The max-
imum trapping time, the activation time with fluoranthene and the
NCE were respectively fixed at 200 ms, 180 ms, and 35%. All ETD
spectra were manually inspected.
X! Tandem Analysis—The analysis of CID and HCD data was
performed with X! Tandem CYCLONE (2011.12.01.1). The S. aga-
lactiae H36B complete database (http://www.ncbi.nlm.nih.gov/
genome/186?project_id  54315) and a contaminant database
(trypsin, keratins, and others classical contaminants) were used.
Enzymatic cleavage was set as a trypsin digestion ([RK] (15)) with
multi possible miscleavage. Precursor mass and fragment mass
tolerance were set to 10 ppm and 0.5 Da, respectively for LTQ
Orbitrap data and to 10 ppm for Q Exactive data. Methionine
oxidation was taken into account as possible modification. A re-
finement search was performed that accepts semi-enzymatic
cleavage of peptide and amino terminus acetylation (42.0105).
Only peptides with an E value smaller than 0.05 were considered for
identification.
To identify glycopeptides in CID data, Ser/Thr/Tyr variable modifi-
cation with HexNAc (203.0793 Da), O-AcHexNAc (245.0912 Da),
and Hex (162.0528 Da) were introduced in the search parameters. In
spectra typical of neutral loss events, the intensity of b and y ions
generated by peptide backbone fragmentation is much lower than the
ion formed by the glycan loss. To take this effect into account, the
dynamic range for scoring spectra was set to 1000.
Development of a New Software Tool for Spectra Comparison
(SpectrumFinder)—The main goal of SpectrumFinder is to compare
pairs of MS/MS spectra, taking into account the fact that the same
peptide sequence carrying different glycans will lead to very similar
fragmentation patterns in HCD after glycan loss.
SpectrumFinder v1.0 is open source software developed for the
need of this study (Fig. 2). It is distributed under the terms of the GNU
Public License version 3 and available for Linux and Windows oper-
ating systems from http://pappso.inra.fr/bioinfo/sf. SpectrumFinder is
written in C. It uses a simple XML parameter file to build a
collection of reference spectra and compare it to other spectra in
mzXML files. The software requires MS/MS spectra recorded on the
same instrument. After an initial spectral cleaning step based on
background subtraction and low cut-off selection performed on a
user-defined number of peaks, all MS2 spectra of a LC run are
compared with a reference spectrum of interest (Fig. 2A) to assess
their similarity. The similarity is established on the basis of different
criteria Fig. 2B. First, a minimum number of shared peaks is required.
Second, a “cosine similarity” is calculated between the two intensity
vectors of paired-peaks. When a peak is absent, a null intensity is
used. The cosine similarity measurement is sensitive to the orientation
but not to magnitude. Consequently, it is a good indicator of common
components between two vectors independently of their intensity.
Third, a linear regression and a Pearson test are calculated between
intensities of all shared peaks. The resulting p value estimates the
similarity between the fragmentation patterns.
SpectrumFinder output is a text file Fig. 2C. Each match between
the reference spectrum and a candidate spectrum is reported on a
separate line. Columns contain information on the computed spec-
trum (scan number, sample name), cosine similarity, linear regression
coefficient, and value of the Pearson test.
In this study, the reference library was deliberately restricted to spec-
tra corresponding to potential glycopeptides (Fig. 3). In each case, the
reference was manually chosen as the best quality spectrum (minimum
six fragment ions with high signal to noise ratio). For each Spectrum-
Finder output, we systematically checked the correspondingMS2 spec-
tra for the presence of diagnostic oxonium ions: m/z 163.0606 (Hex),
FIG. 2. Workflow of SpectrumFinder processing. A, SpectrumFinder searches similar fragmentation pattern among MS2 spectra. Peaks
are extracted from a reference spectrum and compared with an experimental data set. B, Similarities between MS2 spectra are statistically
evaluated and a correlation score is calculated C, When a correlation is considered significant, the mass difference between the precursor ions
of reference/computed spectra is calculated.
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m/z 204.0872 (HexNAc),m/z 366.1400 (HexHexNAc), andm/z 246.0977
(O-AcHexNAc). The mass difference between the parent ions in both
the reference and computed spectra was calculated and manually
fitted with an accuracy of  5 ppm as a combination of glycosylation
(see above X! Tandem analysis) and other modifications: acetylation
(42.0105), formylation (27.9949), methylation (14.0156), water
loss (-18.0153), oxidation of methionine residue (15.9949), acetal-
dehyde (26.01565), and ammonium (17.0265) adducts.
In contrast to other library search tools such as SpectraST (57) or
X!Hunter (58), SpectrumFinder does not use any a priori knowledge
on the mass of the precursor, because only fragment ions are
compared.
Semi-quantitative Analysis of Glycopeptides—A glycoform is a
characterized glycosylation variant of a peptide. The relative abun-
dance of each glycoform of the [192–211] peptide of Srr1 produced in
H36BSrtA* and H36BSrtA*gtfCH strains was calculated by averag-
ing the corresponding XIC peak area measured from three biological
replicates. Normalization was done using the areas of non-glycosy-
lated peptides ([335–345]; [373–387]; and [494–507]).
To perform semi-quantitative analysis of peptide glycoforms, the
area of each peak corresponding to a parent ion was computed from
an extracted ion chromatogram (XIC) with MassChroQ, a software
that performs alignment, XIC extraction, peak detection and quanti-
fication on mzXML data (59) with a 10 ppm tolerance. The relative
proportion of each glycopeptide is reported in Table II.
RESULTS
Enrichment and Monosaccharide Composition of Full-
length Srr1—S. agalactiae Srr1 is a 1310 amino acid protein
with an expected molecular mass of 150 kDa. However upon
SDS-PAGE Srr1 exhibits an apparent mass exceeding 250
kDa. This anomalous migration is likely to be a consequence
of a high glycosylation level (Fig. 1C) combined to unusual
amino acid content (50% of serine and threonine residues)
which can alter the detergent binding capacity as compared
with globular proteins (60, 61). We previously demonstrated a
strong reactivity of Srr1 toward the sWGA lectin, which is
specific to GlcNAc moieties (38). We thus took advantage of
this property to devise a lectin-based enrichment step using
agarose linked sWGA. The efficiency of the strategy is illus-
trated (Fig. 1C): the lectin-based enrichment was required to
detect Srr1 by Coomassie Blue staining. Monosaccharide
composition of purified Srr1 was determined after acid hy-
drolysis by GC-MS analysis of trimethylsilyl derivatives. Two
monosaccharides were identified: GlcNAc and glucose (Glc)
in a 1.8:1 ratio. Unlike what was reported for Srr Fap1 protein
of S. parasanguinis, we did not find any evidence for the
presence of galactose or N-acetylgalactosamine associated
to Srr1 (34).
Glycopeptide Search in CID Spectra of Srr1 Tryptic Pep-
tides—Srr1 tryptic digest was first analyzed by LC-MS/MS on
a LTQ-Orbitrap instrument using CID. Because the highly
repetitive C-terminal domain does not contain any lysine or
arginine residues, the sequence coverage was found to be
restricted to the N-terminal region [93–639] (see supplemental
Fig. S1). As the first 90 residues of Srr1 corresponded to the
atypical signal peptide cleaved by the SecA2 secretion ma-
chinery (62), only residues spanning from 90 to 435 of its
mature form are potentially accessible to trypsin. We ob-
tained 83% sequence coverage for this region (supplemen-
tal Fig. S1).
Because of the lability of the O-glycosidic bonds during CID
experiments (63) glycan loss from the precursor ion is often
the major fragmentation pathway observed in MS/MS spec-
tra. The loss of HexNAc from the [192–211] tryptic peptide at
m/z 1163.5779 leading to an abundant m/z 1062.00 is shown
in Fig. 4A. A MS3 experiment performed on the deglycosy-
lated form of the peptide atm/z 1062.00 confirmed its primary
structure (Fig. 4B).
In order to identify Srr1 glycopeptides, the set of CID spec-
tra was first analyzed with X! Tandem. The automated analysis
of 900 spectra (generated in one LC-MS/MS run), led to the
identification of three peptide sequences [214–233], [234–
247], and [275–285] carrying a monosaccharide (supplemen-
tal Fig. S2A–2D). MS/MS data were also manually inspected,
looking for fragmentation spectra dominated by a single ion
characteristic of a glycan loss event. This manual search led
to the identification of 12 other glycopeptides (Table I). The
highest diversity was observed for the [192–211]peptide
found associated with ten different glycan combinations, a
feature illustrating the heterogeneity of Srr1 glycosylation (Ta-
ble I and supplemental Fig. S3A–3K). Glycosylation with a Hex
was found only on peptides carrying at least four HexNAc (or
O-AcHexNAc, see below), suggesting that the latter modifi-
cation is a prerequisite for further Hex addition. The reactivity
FIG. 3. Schematic overview of Q Exactive data mining with X!
Tandem and SpectrumFinder.
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of Srr1 toward lectin and the monosaccharide composition
analysis of full length protein showed that Srr1 was mainly
modified with GlcNAc and Glc residues, strongly suggesting
that HexNAc and Hex should correspond to these two sugars.
An Unexpected Sugar Modification Identified on Srr1—We
recurrently observed a neutral loss of 245.09 Da in CID spec-
tra (see for example supplemental Fig. S3H, 3N), that was
found either alone or in association with HexNAc moieties on
FIG. 4. Mass spectrometric identification of Srr1 glycopeptides using CID MS/MS. CID-induced neutral loss of 1 HexNAc on the
[192–211] peptide. Three successive MS cycles are shown: (inset A) full MS A, CID fragmentation of the most abundant ion (m/z 1163.5779
z  2) corresponding to the [192–211] peptide modified with one HexNAc as demonstrated by B, the MS3 fragmentation of m/z 1062.00 z 
2.
TABLE I
Report of Srr1 glycosylated peptides identified after neutral loss event in CID MS/MS experiment
Peptide sequence Modification (MH) MS/MS spectraa
S192TSISEVSNILETQASLTDK211 None 2123.0714 Sup. Fig 3A
1 HexNAc 2326.1511 Sup. Fig 3B
2 HexNAc 2529.2308 Sup. Fig 3C
3 HexNAc 2732.3105 Sup. Fig 3D
4 HexNAc 2935.3888 Sup. Fig 3E
4 HexNAc  2 Hex 3259.5066 Sup. Fig 3F
4 HexNAc  3 Hex 3421.5648 Sup. Fig 3G
1 O-AcHexNAc 2368.1613 Sup. Fig 3H
1 O-AcHexNAc  1 HexNAc 2571.2410 Sup. Fig 3I
1 O-AcHexNAc  2 HexNAc 2774.3207 Sup. Fig 3J
1 O-AcHexNAc  3 HexNAc 2977.4004 Sup. Fig 3K
E214SFSANQIVTESSLVTDAGK233 None 2083.0189 Sup. Fig 3L
1 HexNAc 2286.0986 Sup. Fig 3M
1 O-AcHexNAc 2328.1088 Sup. Fig 3N
N234ASVSSLIEITKPK247 None 1486.8475 Sup. Fig 3O
1 HexNAc 1689.9272 Sup. Fig 3P
2 HexNAc 1893.0069 Sup. Fig 3Q
T275GNESLTPTIR285 None 1188.6219 NA
b
1 HexNAc 1391.7016 Sup. Fig 3R
S266QVMIASDKTGNESLTPTIR285 None 2164.0914 Sup. Fig 3S
1 HexNAc 2367.1711 Sup. Fig 3T
a The MS/MS spectra are reported in the corresponding supplemental figures.
b Not Available, MS/MS were selected between 600 and 2000 m/z.
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various peptides of Srr1. This mass did not correspond to any
known post-translational protein modification but was re-
cently associated to O-acetylated GlcNAc on Lactobacillus
plantarum peptidoglycan (see proposed structure Fig. 5A)
(64). To get more insight into the structure of this modification,
CID spectra of oxonium ions at m/z 246.1 produced by ISF
either from peptidoglycan fragments of L. plantarum (Fig. 5B)
or Srr1 peptides (Fig. 5C) were generated and compared. The
two fragmentation profiles matched perfectly and displayed
the presence of ions m/z 210.1 and 228.0 characteristic of
acetylated fragments. It was thus concluded that Srr1 can be
modified by O-AcHexNAc molecule (Fig. 5). The additional
acetylation cannot be precisely located from CID spectra
alone, but the striking similarity between fragmentation pro-
files supports the hypothesis that the precursor ions share the
same structure. The -1,4-glycosidic linkage present in pep-
tidoglycan makes the C4-position unlikely to be modified and
we propose the C6-position as a putative site for the addi-
tional acetylation.
Development of a New Software Tool to Analyze HCD
MS/MS Data Obtained from Glycopeptides—As previously
described, CID spectra of all glycopeptides are poorly inform-
ative because only the glycosidic bond cleavage is observed.
To overcome this problem, we decided to use HCD fragmen-
tation, which is slightly more energetic and allows for consec-
utive fragmentations. Digests previously analyzed on the LTQ
were thus analyzed on a Q Exactive instrument (65). As ex-
pected, HCD MS/MS of glycopeptides was found to lead to
different fragmentation patterns compared with CID. Interest-
ingly, many y ions, characteristic of the backbone cleavage,
could now be observed concomitantly with the formation of
oxonium ions. Furthermore, various glycoforms of a given
peptide were found to generate highly similar y-type ion pro-
files. Hence, glycopeptides sharing the same peptide back-
bone but varying in their glycosylation level display very sim-
ilar fragmentation patterns while having different precursor
masses. As an example, Fig. 6 shows the HCD fragmentation
spectra of two different glycoforms of [192–211] peptide at
m/z 925.4455 and m/z 1101.1749) illustrating the similarity of
y ion profiles and detection of oxonium ions.
A software was developed to exploit the HCD spectra
similarities between different glycoforms of a peptide. The
software, coined Spectrum Finder, was dedicated to the au-
tomated search of specific peptide fragmentation pattern
without a priori on the mass of the precursor (for details see
experimental procedures and http://pappso.inra.fr/bioinfo/sf).
As compared with X! Tandem, analysis of HCD data with
SpectrumFinder revealed additional fragmentation spectra
originating from the same peptide backbones. For each spec-
trum selected by SpectrumFinder, the mass difference be-
tween the precursor ion and the unmodified peptide was
calculated and fitted to a glycan combination of Hex, HexNAc,
and O-AcHexNAc (see experimental procedures and Fig. 2,
Fig. 3). All the glycopeptides previously identified in the CID
experiments (listed in Table I) could be retrieved, demonstrat-
ing the robustness of this new approach. Furthermore, 12
novel glycopeptides could be identified: nine corresponded to
a novel sugar combination on a peptide sequence already
described as glycosylated but two corresponded to peptide
sequences that were not previously found as glycosylated
([255–265] and [451–464]) (Table II).
Using our strategy, 17 variants of the [192–211] peptide
bearing one to seven sugar residues were identified. Impor-
tantly, the semi-quantitative analysis performed on all gly-
coforms of this peptide revealed that the non-glycosylated
form represented less than 1%, whereas more than 80% of
the glycosylated forms corresponded to modifications with
one to four HexNAc residues (Table II). In this regard it
should be stated that HexNAc peptide ion are considered to
be suppressed in favor of non-glycosylated peptides (66).
FIG. 5. Identification of a novel Srr1 glycomodification by characterization of oxonium ionsm/z 246. 0977. Oxonium ions were obtained
by ISF of Lb. plantarum peptidoglycan and Srr1 glycopeptides as indicated under “Experimental Procedures.” A, Proposed structure of
O-AcHexNAc (64). B, CID fragmentation of O-AcHexNAc oxonium ion from a Lactobacillus plantarum peptidoglycan sample. The characteristic
diagnostic ions corresponding to acetylated fragments are: m/z 210.1 and m/z 228.0 as described in (64). C, CID fragmentation of the m/z
246.0977 oxonium ion detected from Srr1 sample.
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As noted above, we confirmed that a Hex was observed
only on HexNAc containing peptides.
Two additional glycoforms carrying HexNAc or O-AcHexNAc
were identified for the [214–233] peptide and one additional
form for [275–285]. The comparison of the extracted ion chro-
matogram peak areas showed that the new glycopeptides
retrieved by SpectrumFinder were of low abundance. These
results highlight the gain of sensitivity provided by this ap-
proach. To check that none of the observed glycoforms were
the result of ISF of larger ones, retention times measured for
16 different glycoforms of the [192–211] peptide were com-
pared (supplemental Fig. S6). Except for the 1 HexNAc and
2 HexNAc glycoforms, all other glycoforms exhibited differ-
ent retention times. This shows that ISF does not lead to a
major bias in our measurements but has in some cases to be
taken into account.
As expected an increase in the number of sugar residues
leads to a shorter retention time. It is worth noting that in
some cases two retention times are observed for the same
glycopeptide, probably resulting in the presence of different
isomers.
Searching HCD MS/MS spectra with SpectrumFinder led to
the identification of a novel segment of Srr1 subject to glyco-
sylation: the [451–464] peptide, which is located distant from
the serine-rich region of the N-terminal part and belongs to
the IgG domain of Srr1 bearing the fibrinogen (Fg) binding
activity (39, 52).
Determination of Glycosylation Sites—ETD has been shown
to be a valuable tool for the analysis of glycopeptides because
the glycosidic bond can be preserved during the fragmenta-
tion process, allowing glycosylation sites to be accurately
mapped (10, 67). Srr1 digest was therefore analyzed in both
untargeted/targeted approaches using ETD as the fragmen-
tation mode. All acquired ETD spectra were manually ana-
lyzed and annotated to locate the modification sites (supple-
mental Fig. S7). When combined, the different runs enabled
FIG. 6.MS2 spectra of two glycoforms of [192–211] peptidefragmented in HCD illustrating the similar y ion profiles. A, Fragmentation
of m/z 925.4455 z  3, corresponding to the peptide 1 O-AcHexNAc and 2 HexNAc. B, Fragmentation of m/z 1101.1749 z  3, ([192–211]
 1 O-AcHexNAc, 3 HexNAc, 2 Hex). Ions atm/z 204.0872, 246.0977, andm/z 366.1400 are oxonium ions. Glycan symbols: HexNAc (Square),
Hex (Circle), O-AcHexNAc (Crossed square).
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the identification of five different peptide sequences bearing
glycosylation (Table III).
In the [192–211] 3 HexNAc glycopeptide (supplemental
Fig. S8A, S8B), Ser207 was unambiguously identified with one
HexNAc, and two other HexNAc that could be restricted to
Ser192, Thr193, Ser194, or Ser196. The lack of fragments within
the first five residues, which contain four potential modified
amino acids, precludes any further assignment. The same pep-
tide was also found with only 1 HexNAc, which can be as-
signed to either Ser192 or Thr193. The glycopeptide [214–233]
was retrieved either with 1 HexNAc or 1 O-AcHexNAc and
Ser226 was modified in both peptides. The [234–247] peptide
was observed to carry either 1 or 2 HexNAc. In both cases
Ser239 was found glycosylated and in the larger peptide an
addition glycan is found on Ser236. In the [275–285] peptide,
Ser279 was found to be modified either by a HexNAc or by a
O-AcHexNAc. The last peptides that have been successfully
fragmented by ETD were [451–464] 1 HexNAc or 1 O-
AcHexNAc. Unexpectedly, only one residue (Thr451) was found
to be modified with a HexNAc-O-AcHexNAc disaccharide. The
presence in the ETD spectrum (supplemental Fig. S8J) of m/z
1748.80, which corresponded to a loss of O-AcHexNAc, indi-
cated that it is the HexNAc moiety which is attached to the
peptide backbone.
In total, six different glycosylation sites could be unambigu-
ously assigned. These results confirm that Srr1 is O-glycosyl-
ated and suggest that serines are preferred over threonines.
Interestingly, we noted that the four identified glycosylated ser-
ines were followed by a leucine, suggesting that the sequon
SerLeu could be a preferred target of GtfAB. However, the
threonine modification demonstrates that glycosylation sites are
flexible.
Influence of GT Encoded in the srr1_locus on Srr1 Glyco-
sylation—WGA lectin binds to all bacterial Srr adhesins tested
so far, indicating that GlcNAc is the predominant sugar in this
family of proteins (Fig. 1B) (35, 54). Our data show that all
glycopeptides carried at least one HexNAc residues, suggest-
ing that this addition could constitute an initial step in Srr1
glycosylation. We have previously shown that the GtfAB GTs
encoded in the Srr1 locus are essential for Srr1 stability (38) as
TABLE II






S192TSISEVSNILETQASLTDK211 None 1.33% Sup. Fig 5A
2 HexNAc 28.7% Sup. Fig 5B
3 HexNAc 26.51% Sup. Fig 5C
1 HexNAc 18.71% Sup. Fig 5D
4 HexNAc 7.00% Sup. Fig 5E
1 O-AcHexNAc  2 HexNAc 5.29% Sup. Fig 5F
4 HexNAc  2 Hex 4.41% Sup. Fig 5G
1 O-AcHexNAc  1 HexNAc 2.32% Sup. Fig 5H
1 O-AcHexNAc  3 HexNAc 2.22% Sup. Fig 5I
1 O-AcHexNAc  3 HexNAc  2 Hex 1.16% Sup. Fig 5J
1 O-AcHexNAc 1.11% Sup. Fig 5K
4 HexNAc  3 Hex 0.74% Sup. Fig 5L
5 HexNAc  2 Hex 0.14% Sup. Fig 5M
2 O-AcHexNAc  1 HexNAc 0.12% Sup. Fig 5N
4 HexNAc  1 Hex 0.1% Sup. Fig 5O
2 O-AcHexNAc 0.08% Sup. Fig 5P
1 O-AcHexNAc  4 HexNAc 0.06% Sup. Fig 5Q
E214SFSANQIVTESSLVTDAGK233 None 77.84% Sup. Fig 5R
1 HexNAc 17.06% Sup. Fig 5S
1 O-AcHexNAc 3.26% Sup. Fig 5T
2 HexNAc 0.84% Sup. Fig 5U
1 O-AcHexNAc  1 HexNAc 0.29% Sup. Fig 5V
N234ASVSSLIEITKPK247 None 93.61% Sup. Fig 5W
1 HexNAc 4.75% Sup. Fig 5X
2 HexNAc 4.01% Sup. Fig 5Y
M255SNESLITPEK265 None 99.3% Sup. Fig 5Z
1 HexNAc 0.7% Sup. Fig 5AA
T275GNESLTPTIR285 None 5.29% Sup. Fig 5AB
1 HexNAc 94% Sup. Fig 5AC
1 O-AcHexNAc 0.52% Sup. Fig 5AD
T451ATLNNQVASIEER464 None 72.12% Sup. Fig 5AE
1 O-AcHexNAc  1 HexNAc 27.44% Sup. Fig 5AF
2 O-AcHexNAc 0.45% Sup. Fig 5AG
a The relative abundance of each precursor was estimated using MassChroQ software.
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opposed to the six GtfC-H GTs (strain H36BSrtA*gtfCH) (38).
However, the protein produced in this genetic background dis-
plays a lower apparent molecular weight on SDS-PAGE that
could be associated with a glycosylation defect (supplemental
Fig. S8). To examine this hypothesis, we compared the abun-
dance of selected Srr1 glycopeptides produced in strains pos-
sessing the full set of GT-encoding genes (H36BSrtA*) or where
the so-called accessory GT-encoding genes were deleted
(H36BSrtA*gtfCH). The Srr1 protein bands were trypsin di-
gested and analyzed on the LTQ-Orbitrap. The XICs corre-
sponding to the glycoforms of the [192–211] peptide (Table I)
were extracted from the two experiments. This peptide was
chosen because of the large abundance and diversity of its
glycoforms. As shown in Fig. 7, all the Hex-containing glyco-
peptides are now absent in the gtfCH strain, suggesting that
one or more of the corresponding GT-encoding genes is in-
volved in its transfer onto GlcNAc-modified residues.
DISCUSSION
Srr proteins constitute a widespread family of bacterial
adhesins expressed in several Gram-positive bacterial spe-
cies of human and veterinary clinical importance. Using MS-
based approaches and dedicated software tool, we demon-
strate that Srr1 produced in S. agalactiae displays a wide
diversity of glycoforms attached to a protein segment located
outside of SR1, the highest Ser/Thr density region of the
N-terminal region (Fig. 8). Some glycopeptides are found with
a various number of sugars, which highlights Srr1 glycosyla-
tion heterogeneity. The most striking example is associated to
the [192–211] peptide that can be modified with at least 16
different combinations of HexNAc and Hex. Semi-quantitative
analysis on this glycopeptide family shows that glycosylated
forms would represent more than 98% of the total amount of
the peptide (Table II). Among the glycoforms observed, some
FIG. 7. Impact of the GtfCH GTs on the abundance of the glycoforms of the [192–211] peptide. The glycoforms of the [192–211] peptide
(Table II) issued from Srr1 synthesized in H36BSrtA* (gray bars) and H36BSrtA*gtfCH (white bars) strains were quantified by calculating the
area of each parent ions computed from XIC and normalized (see experimental procedures). LC-MS/MS experiments were performed in
triplicates and standard deviation (S.D.) is reported for each quantified glycoform. All Hex containing glycoforms were absent in Srr1 produced
in gtfCH background.
TABLE III







S192TSISEVSNILETQASLTDK211 3 HexNAc 911.4421, 3 (S192-S196) and S207 Sup. Fig. 8A
1 HexNAc 776.0556, 3 S192-T193 Sup. Fig. 8B
1 O-AcHexNAc 790.0590, 3 S196 Sup. Fig. 8C
E214SFSANQIVTESSLVTDAGK233 1 HexNAc 762.7047, 3 S226 Sup. Fig. 8D
1 O-AcHexNAc 776.7081, 3 S226 Sup. Fig. 8E
N234ASVSSLIEITKPK247 1 HexNAc 563.9810, 3 S239 Sup. Fig. 8F
2 HexNAc 631.6742, 3 S236 and S239 Sup. Fig. 8G
T275GNESLTPTIR285 1 HexNAc 696.3547, 2 S279 Sup. Fig. 8H
1 O-AcHexNAc 717.3598, 2 S279 Sup. Fig. 8I
T451ATLNNQVASIEER464 1 O-AcHexNAc  1 HexNAc 665.6512, 3 T451 Sup. Fig. 8J
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are not eluted as single and symmetrical peaks (see supple-
mental Fig. S6) suggesting the presence of different positional
isomers that further increase the heterogeneity of the protein.
Monosaccharide composition analysis of full-length Srr1
demonstrated that GlcNAc and Glc were the major sugar
associated to the protein. Although, the present mass spec-
trometry analysis is restricted to the N-terminal part which
contains only a fraction (28 Ser/Thr of the potential O-glyco-
sylation sites (624 Ser/Thr) of Srr1, it is reasonable to assume
that the HexNAc and Hex modifications correspond to
GlcNAc and Glc residues. A definitive conclusion will require
compositional analysis of the N-terminal region.
An additional level of complexity is obtained by the optional
and surprising acetylation of GlcNAc. The same chemical
modification was recently described on the glycan backbone
of L. plantarum peptidoglycan where it provides an increased
resistance toward the muramidase activity of lysozyme (64).
This modification is performed by OatB, a membrane-embed-
ded acetyltransferase, which possesses 40% homology with
Gbs0052, an ortholog present in S. agalactiae. It is possible
that this enzyme also acetylates GlcNAc residues decorating
Srr1. The capacity of an enzyme to act on different surface
compounds is not uncommon; in several Gram-negative spe-
cies it was demonstrated that enzymes belonging to the li-
popolysaccharide biosynthesis machinery were required for
O-glycosylation of flagellins (68–70). It was also found that a
common pentasaccharide is used to O-glycosylate proteins
and synthesize the capsule of the opportunistic pathogen
Acinetobacter baumannii (71). Interestingly, a 245 Da compo-
nent has recently been associated with glycan modifying sur-
face proteins in Campylobacter hominis, the sole Campylo-
bacter species considered as a human commensal (4). That
the same post-translational modification of surface proteins
was found in C. hominis and S. agalactiae, two unrelated
species living in the same environment, could correspond to a
niche-specific adaptation.
In the absence of the gtfCH genes encoding the GTs that
belong to the GT2 and GT8 family (72), Hex-modified [192–
211] glycopeptides are no more detected (Fig. 7). This sug-
gests that the first glycosylation step of Srr1 is the addition of
a GlcNAc residue through GtfAB activity, and is also a strong
indication that the Hex transferring enzyme(s) is encoded by
one of the six deleted genes. In line with this conclusion, it
was recently demonstrated that Gtf3, the S. parasanguinis
ortholog of GtfC (43% identity at the amino acid level), pos-
sesses a glucosyltransferase activity in vitro (73). Importantly,
all O-AcHexNAc modifications were present on Srr1 pro-
duced in the gtfCH strain (Fig. 7) demonstrating that the
enzyme responsible of this modification was not encoded in
the gtfCH locus.
As illustrated in Fig. 8, the [192–211] peptide is located near
the region having the highest serine/threonine density (40–
60%) at the N terminus. A large part of that SR1 region
[133–191] remained undetected in our experiments. This was
not unexpected given the compositional bias (56% Ser/Thr),
size and charge properties of the corresponding tryptic pep-
tide. It is likely that the missing peptide is glycosylated but
cannot be detected in our experimental conditions. In that
respect, Srr proteins resemble eukaryotic O-glycosylated mu-
cins, which are extremely difficult to analyze because of the
heterogeneity and abundance of the glycomodifications (74–
76). In S. gordonii, studies performed on truncated variants of
GspB and based on the reactivity of lectin suggested that only
SR1 region undergoes glycosylation (54). Our results demon-
strate that residues located in the binding region of the protein
such as [451–464] can also be glycosylated.
An important question is to understand what causes the
high heterogeneity of Srr1 glycosylation. The biosynthesis of
glycan and their attachment to proteins is dependent on a
variety of biochemical parameters like the sugar nucleotide
donor availability or the activity of glycosylating enzymes (77).
Because glycosylation of proteins is a non-template process,
variation of these parameters during cultivation could affect
protein glycosylation as it has been shown for eukaryotic
proteins (78). The consequences of varying S. agalactiae cul-
tivation conditions (medium, carbon sources, temperature
etc.) on Srr1 glycosylation characteristics (location, sugars
added, and heterogeneity) could provide valuable clues on
the mechanisms susceptible to influence the pathway.
The biological importance of protein glycosylation and how
it can assist Gram-positive species in their commensal life-
style is an important issue. Unfortunately, our current knowl-
edge of the consequence of Srr1 glycosylation on its func-
FIG. 8. Serine and threonine content of the N-terminal region
of Srr1 in relation with MS-identified peptide and glycopeptide.
The black line displays the serinethreonine content of the sequence,
calculated as a floating average with 50 residues in length sliding
windows and expressed as proportion. The gray lines relate to the
sequence numbering and correspond to region covered by the present
mass spectrometry analysis. The red lines relate to the sequence num-
bering and correspond to glycosylated regions listed in Table II. The
numbering starts at residue 91 corresponding to the secreted form of
the protein.
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tional properties remains limited. Biochemical analysis of Srr
proteins in GT expression mutants have established that
GtfAB-dependent glycosylation is essential for Srr produc-
tion, stability or export depending on the species studied (34,
38, 79, 80). When considering the biology of protein modifi-
cation by GlcNAc, it is important to mention that all major
pathways of central metabolism are required for UDP-GlcNAc
synthesis (66). Thus, it can be hypothesized that O-GlcNAcy-
lation of Srr1 could be indexed to nutrient availability because
the sensor role of this modification is well established in
eukaryotes (66).
Our data indicate that Srr1 glycosylation is not dependent
on a strict consensus sequence, although we observed that
glycosylation of serine was favored when it was followed by a
leucine. There must be some additional structural elements of
Srr1 that might control GT activity. The identification of these
features will require to being able to explore the glycosylation
of regions presenting the highest Ser/Thr density. The
achievement of this objectives could be facilitated by the
development of an in vitro glycosylation model similar to that
developed for Fap1 (33).
Major efforts are underway to elucidate the mechanisms of
bacterial pathogenesis for preventing and treating infections.
A majority of the bacterial glycoproteins identified so far are
localized at the cell-surface where they are involved in a
variety of processes such as biofilm formation, adhesion, cell
motility, or immune system escape (2, 79, 81). In Bacteroides
fragilis, a Gram-negative human symbiont, the general O-gly-
cosylation system is involved in the modification of tens of
proteins, contributes to in vitro fitness of the species and is
also required for the colonization of the mammalian gastro-
intestinal gut (82, 83). These observations support the idea
that protein glycosylation systems participate in the interac-
tion of bacteria with mammalian host and contribute to com-
mensalism or pathogenesis (1, 84).
Surface proteins represent obvious targets for the develop-
ment of vaccines and Srr proteins of S. agalactiae have been
proposed as good candidates (51). In this perspective it will
be important to characterize the glycosylation dynamics of
protein susceptible to be chosen as attractive antigens be-
cause this mechanism could circumvent antibody recognition.
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